A detailed history of Somerset Group LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Somerset Group LLC holds 1,751 shares of LLY stock, worth $1.43 Million. This represents 1.43% of its overall portfolio holdings.

Number of Shares
1,751
Previous 1,908 8.23%
Holding current value
$1.43 Million
Previous $1.48 Million 6.81%
% of portfolio
1.43%
Previous 1.42%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

SELL
$724.87 - $909.04 $113,804 - $142,719
-157 Reduced 8.23%
1,751 $1.59 Million
Q1 2024

May 10, 2024

SELL
$592.2 - $792.28 $13,620 - $18,222
-23 Reduced 1.19%
1,908 $1.48 Million
Q4 2023

Feb 12, 2024

BUY
$525.19 - $619.13 $22,583 - $26,622
43 Added 2.28%
1,931 $1.13 Million
Q3 2023

Nov 13, 2023

BUY
$434.7 - $599.3 $4,347 - $5,993
10 Added 0.53%
1,888 $1.01 Million
Q1 2023

May 11, 2023

BUY
$310.63 - $364.82 $583,363 - $685,131
1,878 New
1,878 $644,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $778B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Somerset Group LLC Portfolio

Follow Somerset Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Somerset Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Somerset Group LLC with notifications on news.